Case Study: How A Multi-Drug Combo For Companion Animals Was Developed And Commercialized
Source: Syngene International Ltd.
Business Problem
One of our leading multi-national animal healthcare clients was working on a novel three-drug combination product for the treatment of seasonal ticks in companion animals.
The client wanted to stabilise a low dose drug which is highly prone to hydrolytic degradation, and also ensure content uniformity of the active within the microgram dosage. The problem was unique and challenging, as the tabletting adjuvants were incompatible, and required our team to think outside the box to develop a stable formulation composition.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Syngene International Ltd.
This website uses cookies to ensure you get the best experience on our website. Learn more